Advanced in Melanoma

Dr. Melissa M. Hardesty

Oncology
Providence
3851 Piper Street, Suite U264, 
Anchorage, AK 
Accepting New Patients
Offers Telehealth
Advanced in Melanoma
Providence
3851 Piper Street, Suite U264, 
Anchorage, AK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Melissa Hardesty is an Oncologist in Anchorage, Alaska. Dr. Hardesty is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Ovarian Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Salpingo-Oophorectomy, and Reconstructive Urology Surgery. Dr. Hardesty is currently accepting new patients.

Her clinical research consists of co-authoring 12 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Obstetrics & Gynecology in AK
Hospital Affiliations
Alaska Native Medical Center
Alaska Regional Hospital
Central Peninsula General Hospital
Providence Alaska Medical Center
Mat-Su Regional Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

3851 Piper Street, Suite U264, Anchorage, AK 99508
Call: 907-562-4673

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO)
A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO)
Enrollment Status: Completed
Publish Date: December 20, 2024
Intervention Type: Drug
Study Drug: Mirvetuximab Soravtansine
Study Phase: Phase 2
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 13, 2023
Intervention Type: Drug
Study Drugs: Abemaciclib, Letrozole
Study Phase: Phase 2
A Phase Ib Safety Run-in and Randomized Phase II, Open-label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of M6620 in Combination With Avelumab and Carboplatin in Comparison to Standard of Care Therapy in Participants With PARPi-resistant Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Phase Ib Safety Run-in and Randomized Phase II, Open-label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of M6620 in Combination With Avelumab and Carboplatin in Comparison to Standard of Care Therapy in Participants With PARPi-resistant Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: November 13, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

12 Total Publications

Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Journal: Gynecologic oncology
Published: August 25, 2025
View All 12 Publications
Similar Doctors
Advanced in Melanoma
Dr. Steven Y. Liu
Oncology | Hematology
Advanced in Melanoma
Dr. Steven Y. Liu
Oncology | Hematology
2925 Debarr Road, Suite 300, 
Anchorage, AK 
 (1.8 miles away)
907-279-3155
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Liu is a Hematologist and an Oncologist in Anchorage, Alaska. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Chronic T-Cell Leukemia (CTCL), Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Testicular Yolk Sac Tumor. Dr. Liu is currently accepting new patients.

Experienced in Melanoma
Dr. Joanie M. Hope
Oncology
Experienced in Melanoma
Dr. Joanie M. Hope
Oncology
3851 Piper Street, Suite U264, 
Anchorage, AK 
 (0.1 miles away)
907-562-4673
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joanie Hope is an Oncologist in Anchorage, Alaska. Dr. Hope is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Salpingo-Oophorectomy, and Hernia Surgery. Dr. Hope is currently accepting new patients.

Experienced in Melanoma
Dr. Qiang Nai
Oncology | Hematology | Hematology Oncology
Experienced in Melanoma
Dr. Qiang Nai
Oncology | Hematology | Hematology Oncology

Alaska Native Tribal Health Consortium

4315 Diplomacy Dr, 
Anchorage, AK 
 (0.8 miles away)
907-563-2662
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Qiang Nai is an Oncologist and a Hematologist in Anchorage, Alaska. Dr. Nai is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Pleuropulmonary Blastoma, Prostate Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor. Dr. Nai is currently accepting new patients.

VIEW MORE MELANOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hardesty's expertise for a condition
ConditionClose
    • Distinguished
    • Cervical Cancer
      Dr. Hardesty is
      Distinguished
      . Learn about Cervical Cancer.
      See more Cervical Cancer experts
    • Endometrial Cancer
      Dr. Hardesty is
      Distinguished
      . Learn about Endometrial Cancer.
      See more Endometrial Cancer experts
    • Malignant Mixed Mullerian Tumor
      Dr. Hardesty is
      Distinguished
      . Learn about Malignant Mixed Mullerian Tumor.
      See more Malignant Mixed Mullerian Tumor experts
    • Ovarian Cancer
      Dr. Hardesty is
      Distinguished
      . Learn about Ovarian Cancer.
      See more Ovarian Cancer experts
    • Ovarian Carcinosarcoma
      Dr. Hardesty is
      Distinguished
      . Learn about Ovarian Carcinosarcoma.
      See more Ovarian Carcinosarcoma experts
    • Sertoli-Leydig Cell Tumor
      Dr. Hardesty is
      Distinguished
      . Learn about Sertoli-Leydig Cell Tumor.
      See more Sertoli-Leydig Cell Tumor experts
    View All 9 Distinguished Conditions
    • Advanced
    • Desmoplastic Small Round Cell Tumor
      Dr. Hardesty is
      Advanced
      . Learn about Desmoplastic Small Round Cell Tumor.
      See more Desmoplastic Small Round Cell Tumor experts
    • Melanoma
      Dr. Hardesty is
      Advanced
      . Learn about Melanoma.
      See more Melanoma experts
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Hardesty is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Hardesty is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Angiomyoma
      Dr. Hardesty is
      Experienced
      . Learn about Angiomyoma.
      See more Angiomyoma experts
    • Bladder Reconstruction
      Dr. Hardesty is
      Experienced
      . Learn about Bladder Reconstruction.
      See more Bladder Reconstruction experts
    • BRCA Positive Breast Cancer
      Dr. Hardesty is
      Experienced
      . Learn about BRCA Positive Breast Cancer.
      See more BRCA Positive Breast Cancer experts
    • Chronic Familial Neutropenia
      Dr. Hardesty is
      Experienced
      . Learn about Chronic Familial Neutropenia.
      See more Chronic Familial Neutropenia experts
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.